Literature DB >> 11719088

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.

Donghui Li1, Pervez F Firozi, Weiqing Zhang, Jianjun Shen, John DiGiovanni, Serrine Lau, Douglas Evans, Helmut Friess, Manal Hassan, James L Abbruzzese.   

Abstract

To test the hypothesis that carcinogen exposure and oxidative stress are involved in pancreatic carcinogenesis in susceptible individuals, aromatic DNA adducts and 8-hydroxyguanosine (8-OH-dG) were measured by (32)P-postlabeling and HPLC-EC, respectively, in 31 pancreatic tumors and 13 normal tissues adjacent to the tumor from patients with pancreatic cancer. Normal pancreatic tissues from 24 organ donors, from six patients with non-pancreatic cancers, and from five patients with chronic pancreatitis served as controls. It was found that tissue samples from patients with pancreatic cancer had significantly higher levels of both aromatic DNA adducts and 8-OH-dG compared with control samples. The mean (+/-S.D.) levels of aromatic DNA adducts were 101.8+/-74.6, 26.9+/-26.6, and 11.2+/-6.6 per 10(9) nucleotides in adjacent tissues, tumors, and controls, respectively. The mean (+/-S.D.) levels of 8-OH-dG were 11.9+/-9.6, 10.8+/-10.6, and 6.7+/-4.6 per 10(5) nucleotides in adjacent tissues, tumors, and controls, respectively. Polymorphisms of the CYP1A1, CYP2E1, NAT1, NAT2, GSTM1, MnSOD, and hOGG1 genes were determined in these patients. The level of aromatic DNA adducts was significantly associated with polymorphism of the CYP1A1 gene. No significant correlation was found between the level of 8-OH-dG and the MnSOD, GSTM1, and hOGG1 polymorphisms. However, one novel polymorphism/mutation of the hOGG1 gene was found in a pancreatic tumor. Mutation at codon 12 of the K-ras gene was found in 25 (81%) of 31 pancreatic tumors, including three G-to-A transitions and 22 G-to-T transversions. Patients with the G-to-T mutation had a significantly higher level of aromatic DNA adducts than those with G-to-A or wild-type codon (P=0.02). On the other hand, the K-ras mutation profile was not related to the level of 8-OH-dG. Given the limitation of sample size, these preliminary data lend further support the hypothesis that carcinogen exposure and oxidative stress are involved in pancreatic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11719088     DOI: 10.1016/s1383-5718(01)00291-1

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  30 in total

Review 1.  Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.

Authors:  Navneet Momi; Sukhwinder Kaur; Moorthy P Ponnusamy; Sushil Kumar; Uwe A Wittel; Surinder K Batra
Journal:  Carcinogenesis       Date:  2012-05-23       Impact factor: 4.944

2.  Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.

Authors:  Kang Guo; Wu-Ping Wang; Tao Jiang; Ju-Zheng Wang; Zhao Chen; Yong Li; Yong-An Zhou; Xiao-Fei Li; Qiang Lu; Lan-Jun Zhang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Genetic polymorphisms of GSTT1, GSTM1, GSTP1, MnSOD, and catalase in nonhereditary chronic pancreatitis: evidence of xenobiotic stress and impaired antioxidant capacity.

Authors:  Sakhawat Hussain Rahman; Chaddha Nanny; Khadija Ibrahim; Derek O'Reilly; Michael Larvin; Andrew J Kingsnorth; Michael J McMahon
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

Review 4.  Targeting reactive oxygen species in development and progression of pancreatic cancer.

Authors:  Nisha Durand; Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2016-11-23       Impact factor: 4.512

5.  CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Miquel Porta; José A Pumarega; Tomàs López; Joan Alguacil; Eva Morales; Núria Malats; Juli Rifà; David J Hunter; Francisco X Real
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

Review 6.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

7.  Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.

Authors:  Li Jiao; Mark A Doll; David W Hein; Melissa L Bondy; Manal M Hassan; James E Hixson; James L Abbruzzese; Donghui Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

8.  Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model.

Authors:  P Vidjaya Letchoumy; K V P Chandra Mohan; J J Stegeman; H V Gelboin; Y Hara; S Nagini
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

9.  Elevated DNA damage response in pancreatic cancer.

Authors:  Michael Osterman; Deion Kathawa; Diangang Liu; Huan Guo; Chao Zhang; Mo Li; Xiaochun Yu; Fei Li
Journal:  Histochem Cell Biol       Date:  2014-07-08       Impact factor: 4.304

Review 10.  Biomarkers of induced active and passive smoking damage.

Authors:  Maura Lodovici; Elisabetta Bigagli
Journal:  Int J Environ Res Public Health       Date:  2009-02-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.